NNT and non-small cell lung carcinoma: The lncRNA nicotinamide nucleotide transhydrogenase-antisense RNA1 (lncRNA NNT-AS1) is remarkably expressed in cisplatin-resistant NSCLC tissues and cells, and NNT-AS1 overexpression can change cell proliferation, the cell cycle, and apoptosis through the MAPK/Slug signaling pathway [167].